- You can view the full Tenet Healthcare Ratings Report.
- Use our health services section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Tenet Healthcare ( THC) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 0.4%. By the end of trading, Tenet Healthcare fell $0.67 (-1.7%) to $39.00 on light volume. Throughout the day, 941,052 shares of Tenet Healthcare exchanged hands as compared to its average daily volume of 1,623,300 shares. The stock ranged in price between $38.99-$40.01 after having opened the day at $39.67 as compared to the previous trading day's close of $39.67. Other companies within the Health Services industry that declined today were: Stereotaxis ( STXS), down 12.7%, Dynatronics Corporation ( DYNT), down 10.9%, Dehaier Medical Systems ( DHRM), down 8.6% and Pingtan Marine Enterprise ( PME), down 7.1%. Tenet Healthcare Corporation, an investor-owned health care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, urgent care centers, and related health care facilities in the United States. Tenet Healthcare has a market cap of $4.1 billion and is part of the health care sector. Shares are up 22.2% year to date as of the close of trading on Friday. Currently there are 7 analysts that rate Tenet Healthcare a buy, no analysts rate it a sell, and 5 rate it a hold. TheStreet Ratings rates Tenet Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity.
